Russia Approves COVID-19 Vaccine Before Trials Completed – Renal and Urology News
President Vladimir Putin claims the vaccine ‘works effectively enough’
Related Articles
CHA2DS2-VASc Score Aligned With Arterial Thromboembolism in Atrial Fibrillation – Renal and Urology News
A study sought to determine the incidence of arterial thromboembolism according to subgroups within a CHA2DS2-VASc score of 1 in patients with AF.
Catheter-Related BSI Risk Low for Both Midline, Peripherally Inserted Central Catheters – Renal and Urology News
Researchers compared the safety and efficacy of midline vs peripherally inserted central catheters in adults receiving medium- to long-term intravenous therapy.
Diabetes Complications More Common in Patients Not Living in Urban Areas – Renal and Urology News
Findings seen for residents of remote areas and small towns compared with those living in cities
Researchers Question Credibility of Subgroup Analyses in Cancer Trials – Renal and Urology News
Subgroup analyses in cancer trials may not be credible, and their results should be interpreted with caution, according to researchers.
Adjuvant Pembrolizumab Prolongs Overall Survival in Clear Cell RCC – Renal and Urology News
One in 5 patients treated with adjuvant pembrolizumab experienced serious adverse events, so it remains important to weigh the risk vs benefits of the therapy…
Artificial Intelligence Gaining Greater Acceptance in Health Care – Renal and Urology News
In a national survey, 72% of individuals believe health advice from a computer chatbot is accurate.
COVID-19 mRNA-1273 Vaccine Safety: Adverse Events of Special Interest – Renal and Urology News
Researchers performed a large-scale safety review to identity adverse events of special interested associated with the COVID-19 mRNA-1273 vaccine.
Concomitant Use of SSRIs and Oral Anticoagulants Increases Major Bleeding Risk – Renal and Urology News
Researchers evaluated whether concomitant use of SSRIs and oral anticoagulants is associated with an increased risk for major bleeding in patients with atrial fibrillation.
Hemodialysis History Does Not Impact Peritoneal Dialysis Dropout – Renal and Urology News
Primary reasons for HD to PD switch include vascular access failure, patient preference, social issues, and cardiovascular disease
Standard-Dose DOAC Equally Efficacious as Low-Dose in AF – Renal and Urology News
A study was conducted to compare the safety and effectiveness of different DOAC dosage regimens in patients with AF, high bleeding risk, and low thrombosis…